Immuno-Oncology Enhances Battlespace Awareness
Molecular Imaging Could Help Clinicians Accurately Select Patients for Treatment or Monitoring
Genome Editing B.C. (Before CRISPR)
Lasting Lessons from the “Old Testament”
Applications of CRISPR/Cas9 Technology in Translational Research on Solid-Tumor Cancers
Efforts Are Underway to Move CRISPR/Cas9 from Bench to Bedside
The Top 15 Best-Selling Drugs of 2017
Amid Talk of Curbing Prices, Most Treatments Show Sales Gains
For full access to this article login to GEN Select now.
Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the <i>GEN</i> Sounds of Science Podcast
- Continuous bioprocessing is generating considerable excitement in the biopharma industry as it promises to increase efficiency, decrease equipment footprint, increase facility flexibility and, ultimately, lower cost of goods. John Sterling, GEN 's editor-in-chief, recently spoke to Merrilee Whitney, director of marketing, next-generation processing at MilliporeSigma, to find out ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.